Filing Details

Accession Number:
0001668397-24-000051
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-06 16:42:41
Reporting Period:
2024-03-04
Accepted Time:
2024-03-06 16:42:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1668397 Medpace Holdings Inc. MEDP Services-Commercial Physical & Biological Research (8731) 320434904
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1677399 J Jesse Geiger C/O Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati OH 45227
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-04 22,321 $90.65 26,145 No 4 M Direct
Common Stock Disposition 2024-03-04 22,321 $403.03 3,824 No 4 S Direct
Common Stock Acquisiton 2024-03-05 17,679 $90.65 21,503 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2024-03-04 22,321 $0.00 22,321 $90.65
Common Stock Employee Stock Option (Right to Buy) Disposition 2024-03-05 17,679 $0.00 17,679 $90.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,679 2024-08-05 No 4 M Direct
0 2024-08-05 No 4 M Direct
Footnotes
  1. The transactions reported on this line of this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
  2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
  3. The option vested in full on August 5, 2019.